LONA Q3 2022 Earnings — LeonaBio, Inc. Revenue & Financial Results | Market Cap Arena

LONALeonaBio, Inc.

$26M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$24M

Net Income

-$20M

EPS (Diluted)

$-4.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$274M

Total Liabilities

$12M

Stockholders' Equity

$262M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$24M	-$18M	-35.4%
Net Income	-$20M	-$16M	-28.8%